Helix BioMedix Welcomes a New CEO

si_promotion_lead_72817

Biopharmaceutical company Helix BioMedix, Inc. has announced the promotion of Robin L. Carmichael to chief executive officer. She will still retain her role as president.

Carmichael will be responsible for all aspects of management of Helix BioMedix, including P&L, operations, sales, marketing, business development, pharmaceutical and consumer product programs, and research and development. She will report directly to the board of directors.

“Robin is a proven leader who has the experience and track record of delivering results. She has a broad understanding of our business and the drive to move the business forward. The board is confident that Robin will lead Helix BioMedix to execute the company’s strategies to innovate and broaden market segments while growing shareholder value,” said R. Stephen Beatty, outgoing CEO. 

“We are transforming to be a faster-growing, more profitable company as we continue a path of evolution in the dermatology and personal care markets." —Robin L. Carmichael, CEO and president of Helix BioMedix, Inc.

With over 25 years of industry experience, Carmichael joined the company in 2007, where she served as vice president of marketing and business development. Later, she was promoted to chief operating officer in 2011. Carmichael became president in  2015. Prior to working for Helix BioMedix, Inc., she worked in similar positions at DERMAdoctor, Inc. and ProCyte Corporation.

“We are transforming to be a faster-growing, more profitable company as we continue a path of evolution in the dermatology and personal care markets," said Carmichael. "I am committed to leading our team to increase our market segments, drive growth and create shareholder value."

Helix BioMedix, Inc. is a biopharmaceutical company with a library of bioactive peptides and patents covering six distinct classes and hundreds of thousands of peptide sequences. Applications for Helix BioMedix peptides include anti-aging, cosmeceutical skin care, and acne treatment as well as other topical anti-infective pharmaceuticals and wound healing applications. 

More in Industry News